Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates

Company Performance - Bausch + Lomb reported quarterly earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.06 per share, but down from $0.13 per share a year ago, representing an earnings surprise of +16.67% [1] - The company posted revenues of $1.28 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.37% and up from $1.22 billion year-over-year [2] - Over the last four quarters, Bausch + Lomb has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - Bausch + Lomb shares have declined approximately 18.9% since the beginning of the year, contrasting with the S&P 500's gain of 8.3% [3] - The current Zacks Rank for Bausch + Lomb is 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $1.27 billion, and for the current fiscal year, it is $0.47 on revenues of $5.03 billion [7] - The outlook for the Medical Services industry, where Bausch + Lomb operates, is currently in the top 37% of over 250 Zacks industries, suggesting potential for better performance compared to lower-ranked industries [8]